UK says it won't pur­chase As­traZeneca's Covid treat­ment due to 'in­suf­fi­cien­t' Omi­cron da­ta — re­ports

Weeks af­ter ev­i­dence sug­gest­ed cur­rent Omi­cron sub­vari­ants may be less sus­cep­ti­ble to As­traZeneca’s pro­phy­lac­tic Covid-19 treat­ment Evusheld, the UK has re­port­ed­ly de­cid­ed against buy­ing dos­es …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER